| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015388527 |
| P356 | DOI | 10.1186/1472-6874-12-12 |
| P932 | PMC publication ID | 3416735 |
| P698 | PubMed publication ID | 22569005 |
| P5875 | ResearchGate publication ID | 224924985 |
| P50 | author | Han G. Brunner | Q22669719 |
| Arjen R Mensenkamp | Q47835094 | ||
| Nicoline Hoogerbrugge | Q56436866 | ||
| P2093 | author name string | Liesbeth Spruijt | |
| Wendy A G van Zelst-Stams | |||
| Judith B Prins | |||
| Marjolijn J Ligtenberg | |||
| Aisha S Sie | |||
| P2860 | cites work | Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2 | Q84588676 |
| Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies | Q24531993 | ||
| Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers | Q24654487 | ||
| Meta-analysis of BRCA1 and BRCA2 penetrance | Q24654786 | ||
| Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers | Q27851474 | ||
| Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 | Q28212276 | ||
| International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience | Q28256780 | ||
| Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial | Q29619615 | ||
| Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial | Q30080035 | ||
| Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition | Q33205307 | ||
| Genetic testing for Lynch syndrome in the first year of colorectal cancer: a review of the psychological impact | Q33423923 | ||
| Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review | Q33594181 | ||
| What do we mean by genetic testing? | Q33679419 | ||
| A Counselling Model for BRCA1/2 Genetic Susceptibility Testing | Q33732256 | ||
| Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial | Q33892091 | ||
| Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation | Q34084471 | ||
| Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality | Q34135443 | ||
| Validation of a decisional conflict scale | Q34321486 | ||
| Shortened time interval between colorectal cancer diagnosis and risk testing for hereditary colorectal cancer is not related to higher psychological distress | Q34565199 | ||
| Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns? | Q35565667 | ||
| Cost effectiveness of a new strategy to identify HNPCC patients | Q35597163 | ||
| Psychological impact of genetic testing for cancer susceptibility: an update of the literature | Q36153016 | ||
| Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement | Q36250211 | ||
| A literature review of the psychological impact of genetic testing on breast cancer patients | Q36293608 | ||
| A heuristics approach to understanding cancer risk perception: contributions from judgment and decision-making research | Q36393347 | ||
| No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study | Q36610368 | ||
| Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors | Q36824748 | ||
| A systematic review of perceived risks, psychological and behavioral impacts of genetic testing | Q37057762 | ||
| Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers | Q37090813 | ||
| The role of BRCA mutation testing in determining breast cancer therapy | Q37808102 | ||
| The decisional conflict scale: further validation in two samples of Dutch oncology patients | Q38437423 | ||
| Impact of Event Scale: A Measure of Subjective Stress | Q39513124 | ||
| Sources of uncertainty about daughters' breast cancer risk that emerge during genetic counseling consultations. | Q39718744 | ||
| Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients | Q39899926 | ||
| Construct validation of the Dutch version of the impact of event scale. | Q42031854 | ||
| Beating the biological clock: the compressed family life cycle of young women with BRCA gene alterations | Q42604721 | ||
| Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer | Q43075431 | ||
| The accuracy of HADS and GHQ-12 in detecting psychiatric morbidity in breast cancer patients | Q43522378 | ||
| Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals | Q46796026 | ||
| Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group | Q47189470 | ||
| Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. | Q50748795 | ||
| The validity of two versions of the GHQ in the WHO study of mental illness in general health care. | Q50959565 | ||
| Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. | Q51016879 | ||
| Time to stop ovarian cancer screening in BRCA1/2 mutation carriers? | Q51125402 | ||
| Psychological side effects of breast cancer screening. | Q51163476 | ||
| Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist. | Q51903542 | ||
| Why GHQ threshold varies from one place to another. | Q51991654 | ||
| Patients’ Memory for Medical Information | Q52106091 | ||
| The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-c30): validation of English version in Singapore. | Q53288017 | ||
| Psychological Impact of Genetic Counseling for Familial Cancer: A Systematic Review and Meta-Analysis | Q60030330 | ||
| Initial cancer genetic counseling consultation: Change in counselees' cognitions and anxiety, and association with addressing their needs and preferences | Q61645367 | ||
| Attitudes about genetic testing for breast-ovarian cancer susceptibility | Q72348210 | ||
| The calculation of breast cancer risk for women with a first degree family history of ovarian cancer | Q72397549 | ||
| A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center | Q73184242 | ||
| Risk estimation for healthy women from breast cancer families: new insights and new strategies | Q75337203 | ||
| Biology of epithelial ovarian cancer: implications for screening women at high genetic risk | Q79840800 | ||
| Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients | Q79880210 | ||
| Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study | Q81432197 | ||
| [Waiting times in breast disease clinics and psychological well-being: speedy care is better care] | Q82971100 | ||
| P921 | main subject | DNA design | Q55213961 |
| P304 | page(s) | 12 | |
| P577 | publication date | 2012-05-08 | |
| P1433 | published in | BMC Women's Health | Q15762590 |
| P1476 | title | DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct | |
| P478 | volume | 12 |
| Q90681972 | Communication about genetic testing with breast and ovarian cancer patients: a scoping review |
| Q42605207 | Effects of a genetic counseling model on mothers of children with down syndrome: a Brazilian pilot study |
| Q57907545 | Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap |
| Q36906183 | High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling |
| Q95934000 | How can Australia integrate routine genetic sequencing in oncology: a qualitative study through an implementation science lens |
| Q40139758 | More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling |
| Q39927173 | Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer |
Search more.